Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of ...
Please provide your email address to receive an email when new articles are posted on . The decision of which type of IOL to implant in a patient is a multistep process in my practice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results